Wednesday, September 10, 2025 – TBA
Satellite Symposium in connection with “get together” – TBA
Thursday, September 11, 2025 – Jarmo Visakorpi Auditorium
Opening session – Chair: TBA
09.00 – 09.10 Opening words – Kalle Kurppa, Tampere University, Finland
09.10 – 09.20 5th Maki Celiac Disease Tampere Prize announcement
Vice Rector Tapio Visakorpi, Tampere University, Finland
09.20 – 09.50 Prize lecture – Awardee
09.50 – 10.20 Keynote lecture: Integrating Type 1 Diabetes and Celiac Disease – TBA
10.20 – 10.50 Coffee break and poster viewing, Arvo Auditorium F025 “Yellow Hall”
Modeling Celiac Disease for personalized clinical applications – Chairs: TBA
10.50 – 11.10 Beyond conventional histology – Kalle Kurppa, University of Tampere, Finland
11.10 – 11.30 Preclinical Celiac Disease models – Keijo Viiri, University of Tampere, Finland
11.30 – 11.50 Omics as personalized clinical tool – Ludvig Sollid, University of Oslo, Norway
Factors modifying Celiac Disease risk and phenotype – Chairs: TBA
12.00 – 12.20 Genetic background of Celiac Disease: current knowledge – Iris Jonkers,
University Medical Center Groningen, The Netherlands
12.20 – 12.40 Microbes as Celiac Disease modifiers – Elena Verdu, McMaster University, Canada
12.40 – 13.00 Insights from birth cohort studies – Daniel Agardh, University of Lund, Sweden
13.00 – 13.20 Oral presentations
13.20 – 14.10 Lunch break and poster viewing, Arvo F025 “Yellow Hall”
Clinical heterogeneity of Celiac Disease – Chairs: TBA
14.10 – 14.30 Diverse clinical presentation of Celiac Disease – Peter Green, Columbia University, U.S.A
14.30 – 14.50 Dermatitis herpetiformis: more than just a skin form of Celiac Disease – Teea Salmi,
Tampere University, Finland
14.50 – 15.10 Neurological manifestations – Marios Hadjivassiliou, University of Sheffield, UK
15.10 – 15.30 Oral presentations
15.30 – 16.00 Coffee break and poster viewing, Arvo F025 “Yellow Hall”
Long-term consequences of Celiac Disease – Chairs: TBA
16.00 – 16.20 Long-term complications: focus on liver, bone, and reproductive issues
Alberto Rubio-Tapia, Cleveland Clinic, Ohio, U.S.A
16.20 – 16.40 Refractory Celiac Disease – Luca Elli, University of Milano, Italy
16.40 – 17.00 Mortality trends across different Celiac Disease phenotypes – Annalisa Schiepatti,
University of Pavia, Italy
17.00 – 17.20 Oral presentations
17.30 – 18.30 Poster rounds, social, wine and cheese, Arvo F025 “Yellow Hall”
20.00 – 24.00 Dinner, Festival Hall Konsu, Puistotorni, Hämeenpuisto 28, Tampere
Friday, September 12, 2025 – Jarmo Visakorpi Auditorium
Personalized prevention and treatment – Chairs: TBA
9.00 – 9.20 Is gluten free diet sufficient for treating Celiac Disease – Jason Tye-Din,
University of Melbourne, Australia
9.20 – 9.40 Novel treatments – overview – TBA
9.40 – 10.00 Restoring tolerance with antigen delivery – TBA
10.00 – 10.40 Oral presentations
10.40 – 11.10 Coffee break and poster viewing, Arvo F025 “Yellow Hall”
Best practices in monitoring Celiac Disease – Chairs: TBA
11.10 – 11.30 Who will manage all adult Celiac Disease patients – TBA
11.30 – 11.50 Follow-up in childhood – Riccardo Troncone, University Federico II, Naples, Italy
11.50 – 12.10 Transition in Celiac Disease – Laura Kivelä, Tampere University, Finland
12.10 – 12.30 Oral presentations
Closing session – Chair: TBA
12.30 – 12.45 Wrap up of the meeting: Where do we stand in 2025? – TBA
12.45 – 12.55 Best Abstract of the Symposium Prize – Katri Lindfors, Tampere University, Finland
12.55 – 13.05 Closing words – Katri Kaukinen, Tampere University, Finland
13.05 – 14.30 Farewell lunch, ARVO Building